Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
3.27 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 67.955 | 46.93 | 66.886 | 94.917 | 77.248 | 77.999 | 130.101 | 157.54 | 111.067 | 108.764 | 122.162 | 135.802 | 68.812 | 41.407 | 43.777 | -6.552 |
Short Term Investments
| 192.517 | 205.582 | 176.636 | 120.517 | 67.633 | 62.41 | 47.504 | 42.654 | 78.844 | 80.326 | 72.075 | 64.162 | 0 | 0 | 0 | 13.104 |
Cash and Short Term Investments
| 260.472 | 252.512 | 243.522 | 215.434 | 144.881 | 140.409 | 177.605 | 200.194 | 189.911 | 189.09 | 194.237 | 199.964 | 68.812 | 41.407 | 43.777 | 6.552 |
Net Receivables
| 0.106 | 0.189 | 0.225 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.109 | 0.109 | 0.109 | 0.109 | 0 |
Inventory
| 0.121 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 6.337 | 3.13 | 2.868 | 3.164 | 4.657 | 3.623 | 2.724 | 2.366 | 1.142 | 3.008 | 4.424 | 4.84 | 1.651 | 0.587 | 0.543 | 0 |
Total Current Assets
| 266.915 | 255.831 | 246.615 | 218.598 | 149.538 | 144.032 | 180.329 | 202.56 | 191.053 | 192.098 | 198.661 | 204.913 | 70.572 | 42.103 | 44.429 | 6.552 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 0.43 | 0.47 | 0.503 | 0.125 | 0.165 | 0.218 | 0.27 | 0.275 | 0.28 | 0.252 | 0.036 | 0.013 | 0.006 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0.184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 20.908 | 44.108 | 62.553 | 67.27 | 27.311 | 43.419 | 15.837 | 0 | 20.001 | 27.658 | 31.619 | 29.91 | 0 | 0 | 0 | 0 |
Tax Assets
| -0.184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.66 | 0.558 | 0.454 | 0.378 | 0.391 | 0.195 | 0.151 | 0.429 | 0.344 | 0.079 | 0.014 | 0.013 | 2.365 | 0.27 | 0 | -6.552 |
Total Non-Current Assets
| 21.998 | 45.136 | 63.51 | 67.773 | 27.867 | 43.832 | 16.258 | 0.704 | 20.625 | 27.989 | 31.669 | 29.936 | 2.371 | 0.27 | 0 | -6.552 |
Total Assets
| 288.913 | 300.967 | 310.125 | 286.371 | 177.405 | 187.864 | 196.587 | 203.264 | 211.678 | 220.087 | 230.33 | 234.849 | 72.943 | 42.373 | 44.429 | 0 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 4.211 | 3.079 | 1.379 | 1.362 | 2.026 | 0.762 | 1.64 | 2.084 | 1.71 | 1.219 | 1.088 | 0.382 | 2.907 | 0.918 | 0.531 | 0 |
Short Term Debt
| 0.125 | 0.121 | 0.866 | 0.002 | 0.029 | 0.067 | 0.105 | 0.133 | 0.142 | 0.139 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 11.031 | 5.272 | 10.726 | 4.734 | 6.476 | 7.95 | 6.067 | 4.396 | 3.282 | 2.578 | 4.059 | 1.107 | 1.611 | 30.264 | 5.836 | 0 |
Total Current Liabilities
| 15.367 | 8.472 | 12.971 | 6.098 | 8.531 | 8.779 | 7.812 | 6.613 | 5.134 | 3.936 | 5.147 | 1.489 | 4.518 | 31.182 | 6.367 | 0 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 28.089 | 27.851 | 27.621 | 0 | 0 | 0 | 0 | 0 | 0.025 | 0.062 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 1.51 | 2.61 | 2.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 174.504 | 56.653 | 56.653 | 0 |
Total Non-Current Liabilities
| 29.599 | 30.461 | 30.181 | 0 | 0 | 0 | 0 | 0 | 0.025 | 0.062 | 0 | 0 | 174.504 | 56.653 | 56.653 | 0 |
Total Liabilities
| 44.966 | 38.933 | 43.152 | 6.098 | 8.531 | 8.779 | 7.812 | 6.613 | 5.159 | 3.998 | 5.147 | 1.489 | 179.022 | 87.835 | 63.02 | 0 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.4 |
Common Stock
| 0.006 | 0.006 | 0.006 | 0.006 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0 | 0 | 0 | 0 |
Retained Earnings
| -258.208 | -237.671 | -222.798 | -206.301 | -193.344 | -181.734 | -170.427 | -157.561 | -146.851 | -136.7 | -127.571 | -119.222 | -115.32 | -53.962 | -26.965 | 0 |
Accumulated Other Comprehensive Income/Loss
| -0.164 | -0.144 | 0.312 | -0.509 | -0.646 | -0.524 | -0.751 | -0.965 | -0.965 | -0.814 | -0.231 | -0.028 | 0 | 0 | 0 | -11.42 |
Other Total Stockholders Equity
| 502.313 | 499.843 | 489.453 | 487.077 | 362.86 | 361.339 | 359.949 | 355.173 | 354.331 | 353.599 | 352.981 | 352.606 | 9.241 | 8.5 | 8.374 | 0 |
Total Shareholders Equity
| 243.947 | 262.034 | 266.973 | 280.273 | 168.874 | 179.085 | 188.775 | 196.651 | 206.519 | 216.089 | 225.183 | 233.36 | -106.079 | -45.462 | -18.591 | 5.98 |
Total Equity
| 243.947 | 262.034 | 266.973 | 280.273 | 168.874 | 179.085 | 188.775 | 196.651 | 206.519 | 216.089 | 0 | 0 | 0 | 0 | 0 | 5.98 |
Total Liabilities & Shareholders Equity
| 288.913 | 300.967 | 310.125 | 286.371 | 177.405 | 187.864 | 196.587 | 203.264 | 211.678 | 220.087 | 230.33 | 234.849 | 72.943 | 42.373 | 44.429 | 5.98 |